Eli Lilly CEO waves off CVS-Novo Nordisk deal
Eli Lilly (LLY) has enjoyed a successful run the past several quarters as the company's blockbuster GLP-1 weight-loss drug Wegovy gains steam in the obesity space. But Wall Street wiped out more than $90 billion in the company's market cap during …